Background: After resection surgery for Crohn's disease, recurrence of endoscopic lesions at the site of the anastomosis or in the neoterminal ileum is graded according to the Rutgeerts score (RS). The goal of this study was to test the interobserver variability for RS. Methods: Thirteen trained endoscopists evaluated the RS on 39 videotapes of patients who had undergone resection for Crohn's disease with an ileocolonic anastomosis 6 months earlier. Videotapes were randomly assigned to endoscopists through a balanced incomplete block design. Each videotape was scored independently by four endoscopists, and each endoscopist evaluated 12 videotapes, making a total of 156 videotape assessments. Reproducibility levels of the RS were assessed through unweighted kappa estimates among multiple raters. The proportion of inappropriate therapeutic initiation was estimated by randomly selecting one endoscopist for each videorecording, assuming that the majority of endoscopists correctly classified endoscopic recurrence.
Introduction
Despite recent advances in medical management, many patients with Crohn's disease (CD) still require intestinal surgery throughout their lives. 1 Surgery is not a cure, and postoperative recurrence is common in patients with CD. 2 Ileocolonoscopy is considered to be the gold standard in the diagnosis and monitoring of CD endoscopic recurrence after surgery, both in clinical trials and clinical practice. [3] [4] [5] [6] [7] [8] [9] [10] [11] Endoscopic activity at the anastomotic site and in the neoterminal ileum after ileocolonic resection is graded using a scoring system developed by Rutgeerts et al. 12 Endoscopic recurrence is commonly defined as a score of i2-i4 (i.e. ≥i2) and used to initiate a new therapy in an attempt to prevent clinical recurrence in the following months. However, since its description in 1990, the properties of the Rutgeerts score (RS) have been poorly studied.
The aim of the present interobserver variation study was to assess the reproducibility level of the RS and to assess how this could affect therapeutic decision-making after surgery.
Patients and methods
The present study was an interobserver variation study performed on videorecorded ileocolonoscopies of patients recruited and followed-up in either of two clinical trials conducted in 11 French centres from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). These two controlled trials (GETAID 2001-1 and GETAID 2001-2) evaluated CD postoperative recurrence in patients receiving 5-aminosalicylate acids (5-ASA), azathioprine (unpublished data), Lactobacillus johnsonii La1, or placebo, respectively. 11 Inclusion criteria for the present study were the following: adults with CD diagnosed according to the usual criteria, bowel resection (right ileocolectomy or colectomy with ileocolic or ileorectal anastomosis) removing all macroscopic intestinal lesions, anastomosis accessible by standard colonoscopy, and complete endoscopic evaluation 6 months after surgery and with videorecording. Patients with colo-colic or colorectal anastomosis and patients whose ileocolonoscopy was not recorded were excluded. All subjects gave written informed consent for these studies, which were approved by the Ethics Committee.
Endoscopists involved in the interobserver variation study were operators trained in inflammatory bowel disease and using RS in current practice. Allocation of the videos to be assessed by each of the 13 endoscopists was performed through a balanced incomplete block randomization so that each of the 39 videos was evaluated independently by four endoscopists blinded to the patient's characteristics. Each endoscopist evaluated 12 videos, and 156 videotape assessments were performed (detailed data are provided in the supplementary material table). Endoscopists evaluated the RS using its definition and five-grade scale (i0 to i4) ( Table 1) . 12 The reproducibility levels of the RS were assessed through unweighted kappa estimates among multiple raters. 13 Agreement was determined for the RS relative to the cut-off of ≥i2 and relative to the cut-off of >i2 being used to define severe endoscopic recurrence). The agreement was considered as 'moderate' for kappa values of 0.41-0.60, 'substantial' for kappa values of 0.61-0.80, and almost perfect for kappa values above 0.80. 14 We first assumed that a score of ≥i2 would trigger initiation of medical therapy. This cut-off value has been used as the main end point in most clinical trials studying the prevention of postoperative recurrence in CD. 3, [6] [7] [8] [9] [10] [11] When using this assumption, the four assessors may disagree on the need for medical therapy because they disagree on RS relative to i2; for instance, one may score i1 and the three others i2. To estimate the proportion of inappropriate therapeutic initiations, we assumed that when three assessors agreed on the RS relative to the cut-off used to initiate intervention (i.e. three evaluations under the cut-off or, alternatively, three evaluations at or above the cut-off), their evaluation led to an appropriate therapeutic initiation. Thus, the evaluation of the last assessor, the one who disagreed with them, would have led to an inappropriate therapeutic initiation. Consequently, if we selected at random one of the four assessors when three assessors agreed and the fourth differed, 25% of the selections would have led to an inappropriate therapeutic initiation. When two assessors made an evaluation indicating therapeutic initiation, whereas the other two made an evaluation indicating the opposite decision, any assessor had a 50% chance of recommending appropriate therapeutic initiation according to the criteria. Consequently, if we selected at random one of the four assessors when two assessors agreed on therapeutic initiation and two on no therapeutic initiation, half the selections would have led to an inappropriate therapeutic initiation. In all other situations, all assessors agreed, and if we selected at random one assessor, none would have indicated an inappropriate therapeutic initiation. According to the number of cases in which each situation was observed, it was possible to calculate, through binomial distribution, the probability that an evaluation would have led to an inappropriate therapeutic initiation when selecting at random one endoscopist out of the four who assessed each of the 39 videorecordings (see the supplementary appendix for detailed calculations). i0: no lesion i1: ≤5 aphthous lesions i2: >5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis i3: diffuse aphthous ileitis with diffusely inflamed mucosa i4: diffuse inflammation with larger ulcers, nodules, and/or narrowing The same type of calculation was repeated, but assuming that a score of >i2 was used to initiate a new treatment.
These calculations allowed us to estimate the difference in the proportions of inappropriate therapeutic initiations (with the 95% confidence interval) when using ≥i2 versus ≥i3 as the cut-off RS, taking into account the pairing of these data.
All results (kappa values and the probabilities of an evaluation leading to an appropriate therapeutic initiation) are presented as estimate ± standard error (SE) (95% confidence interval). Analyses were performed with the software SPSS ® .
Results
The clinical characteristics of the 39 patients are displayed in Table 2 .
The unweighted kappa ± SE estimate for the RS was 0.43 ± 0.05 (0.33-0.52) on a 5-grade scale, showing 'moderate' agreement. The kappa estimate ± SE was 0.47 ± 0.10 (0.28-0.65) for the RS relative to the cut-off value of i2 or more ('moderate' agreement), and 0.64 ± 0.11 (0.42-0.85) for the RS relative to the cut-off value of >i2 ('substantial' agreement).
When initiating treatment for a RS of ≥i2, assuming that the majority of assessors made the correct evaluation for appropriate therapeutic initiation, the estimate of the number of evaluations leading to an inappropriate therapeutic initiation was 5.00, with a variance of 3.25, leading to an estimate of the probability of inappropriate therapeutic initiation of 12.8% (3.8-21.9), which corresponds to one in eight patients. When deciding on treatment for a RS of >i2, the estimated number of evaluations leading to an inappropriate therapeutic initiation was 3.25, with a variance of 2.06, leading to an estimate of the probability of inappropriate therapeutic initiation of 8.3% (1.1-15.6). The estimated difference between the number of evaluations leading to an inappropriate therapeutic initiation according to the cut-off of ≥i2 versus >i2 was 1.75, with a variance of 4.44, taking into account the pairing of these two numbers evaluated on the same videotapes, leading to a difference in the probability of inappropriate therapeutic initiation of 4.5% (-6.1-15.1) (p = 0.41).
Discussion
To our knowledge, the present study is one of the first that has formally assessed the interobserver variation for RS. In addition, it attempted to derive the consequences of the variation in RS evaluation in terms of a patient's management. The main result is that the reproducibility of RS evaluation on a 5-grade scale was moderate, as was its evaluation relative to a cut-off of < i2 versus a cut-off > or = i2 indicating therapeutic initiation. As a consequence of the latter variation, we estimated that one therapeutic decision out of eight could be inappropriate.
Only three other studies have estimated the reproducibility level of the RS score on a 5-grade scale. In the Daperno et al. study, 10 postoperative CD colonoscopies were evaluated by 14 experts, leading to 140 assessments. 15 In the Kennedy et al. study, 43 colonoscopies were evaluated by five experts, leading to 215 assessments. 16 In the Gesce et al. study, 25 colonoscopies were evaluated three times by four experts, leading to 100 independent assessments. 17 In our study, 13 experts were involved in the evaluation of 39 colonoscopies, leading to 156 assessments. As a consequence of the assignment of assessments through an incomplete balanced block design, the endoscopist and colonoscopy samplings were rather large in our study, with the total number of assessments being similar to that in the three previous studies.
The kappa estimates for RS evaluation on a 5-grade scale were quite similar in three studies: 0.53 in the Daperno et 16 and in the present study (0.76). Nevertheless, when using ICC instead of unweighted kappa to estimate the agreement level of the RS on a 5-grade scale, much higher levels of agreement were systematically obtained, corresponding to an almost perfect agreement when applying the same rules to the ICC as those used for kappa. This apparent contradiction is the consequence of the equivalence between ICC and weighted kappa for ordinal data that are using unit distance between adjacent categories and square distance weights for weighted kappa. Weighted kappa consists of considering what the disagreements between observers' quotations contribute partially to agreement if they are not extreme. This contribution is quantified by a decreasing weight when quotations diverge on the ordinal scale. When using the square distance weighted kappa for RS, weights would be: 1 for perfect agreement, 0 for maximal disagreement (i0 and i4), 0.75 in the case of disagreement between i0 and i2, i1 and i3, or i2 and i4, and 0.44 in the case of disagreement between i0 and i3, or i1 and i4. It means that two disagreements from i0 and i3, having a total weight of 0.88, would provide a similar contribution to agreement than one perfect agreement weighted 1.00. This demonstrates that, converse to unweighted kappa, ICC overestimates agreement level of RS on a 5-grade scale, by giving too much weight to major disagreements. This criticism holds for recent publications using widely ICC to assess agreement level of ordinal scores in inflammatory bowel disease (see for instance Mosli et al. 18 for histological assessment of disease severity in ulcerative colitis).
The kappa estimates for RS evaluation relative to <i2 versus ≥i2 were 0.83 in the Kennedy et al. study 16 and 0.47 in our study. This large difference could be the consequence of colonoscopy sampling. Indeed, in the Kennedy et al. study, 16 only seven colonoscopies (16%) were rated i2 and 15 (35%) i3 or i4 by the original endoscopist, compared with 19 (49%) and 4 (10%) in our study, Data from the present study are of importance when considering clinical trials that have looked at the efficacy of various drugs to prevent CD postoperative recurrence using the i2 threshold. [3] [4] [5] [6] [7] [8] [9] [10] [11] Meta-analysis of studies testing placebo, 5-ASA, thiopurines, or anti-TNF agents in this setting have shown the superiority of biologics over all other treatments. 20 However, the interobserver variation observed in the present study may lead to an erroneous assessment with potential therapeutic consequences in at least 13% of the cases. When considering only severe postoperative recurrence, defined as a RS >i2, this meta-analysis suggests that biologics were more effective than immunosuppressants, with a difference not reaching statistical significance. 20 It should be noted that, for this threshold, the proportion of erroneous therapeutic decisions was only 8% in the present series. This proportion was not significantly different from the 13% estimated for a RS of ≥i2 or more, probably due to the small number of colonoscopies graded i3 or i4 in our sample. In clinical practice, it does not mean that therapeutic decisions would be more appropriate when using an i3 threshold instead of an i2 threshold: treating only patients with RS >i2 would probably avoid overtreatment but may undertreat some patients with a high risk of clinical relapse. Development of new tools for assessing CD postoperative recurrence in addition to RS, such as magnetic resonance imaging or faecal calprotectin, may help the physician to refine the best therapeutic approach in this situation.
One of the strengths of the present study was the experience of and the large number of endoscopists who had previously used the RS for years in daily practice and clinical trials. 11 We acknowledge, that despite four-fold assessments, the low number of patients with severe endoscopic lesions is a limitation. Furthermore, it has not been possible to assess in the same time the quality of the videos, especially bowel preparation and recording.
In conclusion, the variability of the RS appears large and the reproducibility for lesions i2 or more was only moderate. Thus, when solely based on the RS, management of patients with CD postoperative recurrence may lead to wrong therapeutic initiations. Reasons for the variation in the RS evaluation should be studied in an attempt to increase its reproducibility.
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